acetyl-l-carnitine hepatic encephalopathy randomized trial doi Oral treatment in encephalopathy: view of evidence-based medicine Future Therapies of Hepatic Encephalopathy

Basic fibroblast growth factor (bFGF) protects hippocampal and cortical neurons against glutamate toxicity by changing the expression of -methyl-D-aspartic acid (NMDA) receptors and antioxidant enzymes like superoxide dismutases and glutathione reductase [124]

What works exceptionally well for one man may be less effective for another

CONFLICTS OF INTEREST: The authors declare that there are no conflicts of interest associated with this manuscript

[13] Chloramphenicol has been shown to blunt reticulocyte response to cyanocobalamin, while ethanol, colchicine, and nitrous oxide interfere with cobalamin metabolism or utilization, each warranting clinician awareness when evaluating suboptimal treatment outcomes

Stopping either drug often leads to weight regain because the appetite-suppressing effects end when the medication stops

Antioxidant levels do not change overnight